UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Pacira BioSciences
PCRX
$974M
| $1.95M | ﹤0.01% |
47,810
+4,618
| +11% | +$184K |
|
1602
Samsara
IOT
$23.2B
| $1.95M | ﹤0.01% |
98,688
+28,582
| +41% | +$453K |
|
1603
United Natural Foods
UNFI
$2.8B
| $1.94M | ﹤0.01% |
73,805
-19,388
| -21% | -$707K |
|
1604
Delek US
DK
$3.72B
| $1.94M | ﹤0.01% |
84,660
-8,780
| -9% | -$220K |
|
1605
Seacoast Banking Corp of Florida
SBCF
$3.37B
| $1.94M | ﹤0.01% |
81,933
+3,543
| +5% | +$105K |
|
1606
Appian
APPN
$2.55B
| $1.93M | ﹤0.01% |
43,586
+2,502
| +6% | +$101K |
|
1607
Talos Energy
TALO
$2.6B
| $1.93M | ﹤0.01% |
130,230
-105,274
| -45% | -$1.81M |
|
1608
ZIM Integrated Shipping Services
ZIM
$3.04B
| $1.93M | ﹤0.01% |
81,886
-223,118
| -73% | -$4.69M |
|
|
LGF.B
1609
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $1.92M | ﹤0.01% |
185,438
+18,643
| +11% | +$159K |
|
|
ZUO
1610
DELISTED
Zuora, Inc.
ZUO
| $1.92M | ﹤0.01% |
194,807
+36,213
| +23% | +$303K |
|
|
SFBS
1611
ServisFirst Bancshares
SFBS
$4.84B
| $1.92M | ﹤0.01% |
35,224
-1,677
| -5% | -$112K |
|
1612
Evertec
EVTC
$1.77B
| $1.92M | ﹤0.01% |
56,834
-15,020
| -21% | -$528K |
|
1613
Cohu
COHU
$2.34B
| $1.92M | ﹤0.01% |
49,964
-1,450
| -3% | -$52.5K |
|
|
NEX
1614
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $1.92M | ﹤0.01% |
241,148
+4,540
| +2% | +$40.6K |
|
1615
Semtech
SMTC
$12.2B
| $1.91M | ﹤0.01% |
79,290
+5,271
| +7% | +$165K |
|
1616
Matthews International
MATW
$717M
| $1.9M | ﹤0.01% |
52,823
| – | – |
|
1617
Encore Capital Group
ECPG
$2.01B
| $1.9M | ﹤0.01% |
37,755
+1,308
| +4% | +$68.4K |
|
|
CVSA
1618
Covista Inc
CVSA
$4.38B
| $1.9M | ﹤0.01% |
49,214
-4,606
| -9% | -$176K |
|
1619
Warrior Met Coal
HCC
$5.04B
| $1.9M | ﹤0.01% |
51,765
+8,960
| +21% | +$331K |
|
1620
Xenon Pharmaceuticals
XENE
$6.21B
| $1.9M | ﹤0.01% |
53,052
+14,114
| +36% | +$521K |
|
1621
News Corp Class B
NWS
$17.6B
| $1.9M | ﹤0.01% |
108,756
+3,816
| +4% | +$70.5K |
|
1622
Laureate Education
LAUR
$5.13B
| $1.89M | ﹤0.01% |
160,973
+22,830
| +17% | +$251K |
|
1623
Upbound Group
UPBD
$1.12B
| $1.88M | ﹤0.01% |
76,843
+4,521
| +6% | +$116K |
|
1624
Worthington Enterprises
WOR
$2.79B
| $1.88M | ﹤0.01% |
47,143
+2,960
| +7% | +$105K |
|
1625
Addus HomeCare
ADUS
$2.23B
| $1.87M | ﹤0.01% |
+17,500
| New | +$1.83M |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.